If you purchased or acquired securities in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...

WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMD ...

Analysts predict an EPS of $0.22 and revenue of approximately $109.5 million for the upcoming quarterly report. Legal ...

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts ...

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TransMedics Group, ...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...

We remain optimistic about Australian healthcare investments, with key trials and FDA approvals expected in 2025, potentially ...

Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of TransMedics Group, Inc. between February 28, 2023 and ...